methylprednisolone has been researched along with Amyloid Angiopathy, Cerebral in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Lv, Y; Xia, C | 1 |
| Carlson, A; Gyang, TV; Kresak, J; Rees, J; Rempe, T; Rodriguez, E; Sollero, CEV; Tuna, IS; Viswanathan, VT | 1 |
| Day, GS; Fagan, AM; Henson, RL; Morris, JC; Plotzker, AS | 1 |
| Bailey, M; Gera, A; Witek, N | 1 |
| Berg, A; Cagle, K; Freeman, J | 1 |
| Breiner, A; Casaubon, LK; MacLellan, A; Tang-Wai, DF | 1 |
| Anderson, NE; Barber, PA; Chung, KK; Hutchinson, D; Synek, B | 1 |
| Iwanaga, T; Kaneko, N; Kimura, K; Nishimura, H | 1 |
| Chin, SS; Elkind, MS; Gupta, R; Khandji, AG; Krakauer, JW; Oh, U | 1 |
9 other study(ies) available for methylprednisolone and Amyloid Angiopathy, Cerebral
| Article | Year |
|---|---|
Cerebral amyloid angiopathy-related inflammation with posterior reversible encephalopathy syndrome-like presentation: a case report.
Topics: Apolipoprotein E4; Cerebral Amyloid Angiopathy; Humans; Inflammation; Methylprednisolone; Posterior Leukoencephalopathy Syndrome; Seizures | 2022 |
Corticosteroids lead to short-term improvement in cerebral amyloid angiopathy-related inflammation.
Topics: Adrenal Cortex Hormones; Aged; Brain; Cerebral Amyloid Angiopathy; Female; Humans; Inflammation; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Prednisolone; Retrospective Studies | 2020 |
Clinical and Paraclinical Measures Associated with Outcome in Cerebral Amyloid Angiopathy with Related Inflammation.
Topics: Aged; Aged, 80 and over; Amyloid beta-Peptides; Anti-Inflammatory Agents; Biomarkers; Cerebral Amyloid Angiopathy; Cognitive Dysfunction; Critical Care; Electroencephalography; Encephalitis; Female; Humans; Leukocytosis; Longitudinal Studies; Magnetic Resonance Imaging; Male; Methylprednisolone; Neuroimaging; Peptide Fragments; tau Proteins; Treatment Outcome | 2021 |
Pearls & Oy-sters: CAA-related inflammation presents as subacute cognitive decline in a patient with Parkinson disease.
Topics: Aged; Brain Edema; Cerebral Amyloid Angiopathy; Cognitive Dysfunction; Frontal Lobe; Glucocorticoids; Humans; Inflammation; Magnetic Resonance Imaging; Male; Methylprednisolone; Parkinson Disease; White Matter | 2019 |
Cerebral Amyloid Angiopathy with Angiitis: Emerging Options for Treatment.
Topics: Aged; Anti-Inflammatory Agents; Azathioprine; Brain; Cerebral Amyloid Angiopathy; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Methylprednisolone; Prednisone; Tomography, X-Ray Computed; Treatment Outcome; Vasculitis | 2015 |
Clinical Reasoning: A case of subacute cognitive decline in a 76-year-old man.
Topics: Aged; Cerebral Amyloid Angiopathy; Cognition Disorders; Humans; Leukoencephalopathies; Male; Methylprednisolone; Neuroprotective Agents | 2016 |
Cerebral amyloid angiopathy related inflammation: three case reports and a review.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Anti-Inflammatory Agents; Blood Vessels; Brain; Cerebral Amyloid Angiopathy; Cerebral Cortex; Cyclophosphamide; Dexamethasone; Fatal Outcome; Female; Headache; Humans; Immunosuppressive Agents; Inflammation; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Paresis; Prognosis; Seizures; Tomography, X-Ray Computed | 2011 |
[Cerebral amyloid angiopathy-related leukodystrophy: a case report].
Topics: Aged, 80 and over; Cerebral Amyloid Angiopathy; Female; Humans; Leukoencephalopathies; Magnetic Resonance Imaging; Methylprednisolone; Prednisolone; Pulse Therapy, Drug; Treatment Outcome | 2012 |
Reversible leukoencephalopathy associated with cerebral amyloid angiopathy.
Topics: Aged; Aged, 80 and over; Aphasia; Brain Chemistry; Brain Edema; Cerebral Amyloid Angiopathy; Confusion; Dexamethasone; Female; Hemosiderin; Humans; Ischemic Attack, Transient; Magnetic Resonance Imaging; Male; Methylprednisolone; Myelin Sheath; Seizures | 2004 |